XML 37 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Earnings (Loss) per Share (Tables)
 6 Months Ended
Jun. 30, 2016
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Earnings (Loss) Per Share
The following table sets forth the computation of basic and diluted earnings (loss) per share for the three and six months ended June 30, 2016 and 2015:
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2016
 
2015
 
2016
 
2015
 
(in thousands, except per share amounts)
Net income (loss) from continuing operations attributable to The Medicines Company
$
181,823

 
$
(67,445
)
 
$
91,480

 
$
(63,072
)
Income (loss) from discontinued operations, net of tax
619

 
20,853

 
(1,486
)
 
21,514

Net income (loss) attributable to The Medicines Company
$
182,442

 
$
(46,592
)
 
$
89,994

 
$
(41,558
)
 
 
 
 
 
 
 
 
Weighted average common shares outstanding, basic
69,711

 
65,903

 
69,464

 
65,541

Plus: net effect of dilutive stock options, warrants, restricted common shares and shares issuable upon conversion of notes
2,798

 
—

 
2,848

 
—

Weighted average common shares outstanding, diluted
72,509

 
65,903

 
72,312

 
65,541

 
 
 
 
 
 
 
 
Basic earnings (loss) per common share attributable to The Medicines Company:
 
 
 
 
 
 
 
Earnings (loss) from continuing operations
$
2.61

 
$
(1.02
)
 
$
1.32

 
$
(0.96
)
Earnings (loss) from discontinued operations
0.01

 
0.31

 
(0.02
)
 
0.33

Basic earnings (loss) per share
$
2.62

 
$
(0.71
)
 
$
1.30

 
$
(0.63
)
 
 
 
 
 
 
 
 
Diluted earnings (loss) per common share attributable to The Medicines Company:
 
 
 
 
 
 
 
Earnings (loss) from continuing operations
$
2.51

 
$
(1.02
)
 
$
1.27

 
$
(0.96
)
Earnings (loss) from discontinued operations
0.01

 
0.31

 
(0.02
)
 
0.33

Diluted earnings (loss) per share
$
2.52

 
$
(0.71
)
 
$
1.25

 
$
(0.63
)